- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Giant cell arteritis (GCA)
- Meeting Date: November 2018
- Public Summary Document (PSD) November 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2018 PBAC Meeting - Word
Tocilizumab – November 2018
Tocilizumab: Injection 162 mg in 0.9 mL pre-filled pen, Injection 162 mg in 0.9 mL pre-filled syring
Last updated
15 March 2019